Nasal Spray Flu Vaccine Recommended for Young Children

An advisory panel to the Centers for Disease Control and Prevention voted to recommend the nasal spray influenza vaccine as an option for children aged two to five years. This recommendation expands the types of available influenza vaccines for young children.

The CDC's Advisory Committee on Immunization Practices, ACIP, made the recommendation during a meeting Wednesday, according to agency reports. The panel reviewed data on vaccine effectiveness and safety before the vote.

The nasal spray vaccine, also known as the live attenuated influenza vaccine, LAIV, offers an alternative to the traditional flu shot, otherwise known as the inactivated influenza vaccine, IIV. The updated guidance now allows health providers to administer either the flu shot or the nasal spray in certain young patients.

Health officials emphasize that flu vaccines remain the most effective way to prevent influenza and its potentially serious complications. The CDC continues to encourage annual flu vaccination for all eligible individuals six months and older. Specific recommendations for the 2024-2025 flu season will be released later this year.